Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc.
1. A class action lawsuit has been filed against Cassava Sciences. 2. Allegations include misleading statements about simufilam's efficacy for Alzheimer's Disease. 3. Investors affected from February 7, 2024, to November 24, 2024 may join. 4. Lead plaintiff deadline is February 10, 2025. 5. Lawsuits can instigate significant volatility in stock prices.